Updated: Odyssey CEO talks about $279M IPO and building a 'permanent' biotech

🌐 Endpoints News — 2026-05-08

Odyssey CEO has announced a $279 million IPO, highlighting the company's plans to establish itself as a significant player in the biotech industry. This financial move is expected to attract considerable interest from investors.

Markets Deals AI & Tech Odyssey IPO biotech investment market

Read original source →

Circle Raises Funding at $3 Billion Valuation for Arc Blockchain
The Information — 2026-05-11
U.S. Bonds Hit 5%: Mayday
Seeking Alpha — 2026-05-11
IDGT: Why The AI Infrastructure Cycle May Still Be Early
Seeking Alpha — 2026-05-11
Here’s the next AI ‘battleground’ — and how investors can get in on the action
MarketWatch — 2026-05-11
AAON: Shares Are Overheating (Downgrade)
Seeking Alpha — 2026-05-11
IREN's Real Moat Is Becoming Clearer
Seeking Alpha — 2026-05-11

Updated: Odyssey CEO talks about $279M IPO and building a 'permanent' biotech

AI Summary

Related Articles

Circle Raises Funding at $3 Billion Valuation for Arc Blockchain

U.S. Bonds Hit 5%: Mayday

IDGT: Why The AI Infrastructure Cycle May Still Be Early

Here’s the next AI ‘battleground’ — and how investors can get in on the action

AAON: Shares Are Overheating (Downgrade)

IREN's Real Moat Is Becoming Clearer